Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram and Copper Gluconate in Recurrent Glioblastoma
NCT03034135Phase 2Completed
- Sponsor
- Cantex Pharmaceuticals, Inc.
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of disulfiram, copper gluconate in glioblastoma (GBM), sponsored by Cantex Pharmaceuticals, Inc.. Started Mar 2017; status: completed.
02
Drugs
disulfiramcopper gluconate
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03034135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03034135.